HMH Maestro
  • Action Center
  • Topics
  • On-Call Schedules
  • CME
  • Helpful Tools
Open main menu
  • Action Center
  • Topics
  • On-Call Schedules
  • CME
  • Helpful Tools
  • Topics
  • Featured Specialties
  • Hackensack Meridian Childrens Health Childrens Cancer Institute Now a Member of the Prestigious Pacific Pediatric NeuroOncology Consortium PNOC

Hackensack Meridian Childrens Health Childrens Cancer Institute Now a Member of the Prestigious Pacific Pediatric NeuroOncology Consortium PNOC

Published:
July 22, 2021

What you need to know

The Children’s Cancer Institute (CCI) is now a member of the
Pacific Pediatric Neuro-Oncology Consortium (PNOC.) The CCI, whose pediatric cancer program is ranked among the best in the country by U.S. News & World Report, joins an international group of consortium member hospitals in the United States which includes Johns Hopkins Hospital in Baltimore and Children’s Hospital of Philadelphia.

The Children’s Cancer Institute met the criteria for admission because, like other participating hospitals, it has:

  • Specialists in different areas of pediatric brain tumor treatment – such as oncology, neurosurgery, and radiation therapy – who combine their expertise to optimize care for each patient;
  • Care teams made up of nurses, social workers, psychologists, and hospital staff with an in-depth understanding of the needs of families and children suffering from brain tumors;
  • Finally, each site has scientists actively engaged in laboratory research on pediatric tumor biology who work with clinicians to turn their findings into therapies.

Information about The Pacific Pediatric Neuro-Oncology Consortium

Brain tumors are the most common solid tumors in children. The Pacific Pediatric Neuro-Oncology Consortium (PNOC) was formed to provide children with brain tumors access to innovative treatments through clinical trials. The clinical strategies behind these trials are based on the investigation of the molecular and genetic makeup of brain tumors.

The news of the admission into consortium coincides with news of a soon-to-be opened pediatric neuro-oncology laboratory – the first of its kind in New Jersey – at the Hackensack Meridian Health Center for Discovery and Innovation (CDI.)

The Neuro-oncology Section of the Children’s Cancer Institute

The Neuro-oncology Section of the Children’s Cancer Institute is a program of the Pediatric Hematology-oncology and Bone Marrow transplant/Cellular Therapy Division. The division provides care to patients with cancer, blood disorders and immunodeficiencies at Joseph M. Sanzari Children’s Hospital and K. Hovnanian Children’s Hospital. This year, for the second consecutive year, the Hackensack Meridian Children’s Health pediatric cancer program was ranked among the Top 50 in the country by U.S. News & World Report’s Best Children’s Hospital Report.

  1. Clinical Alerts
  2. Featured Physicians
  3. Featured Specialties
  4. HMH Partners Updates
  5. Hospitals and Locations
  6. IT Alerts
  7. Leadership Announcements
  8. Legal and Regulatory
  9. Payor Updates
  10. Physician Tips
  11. Quality and Safety
  • Topics
  • Featured Specialties
  • Hackensack Meridian Childrens Health Childrens Cancer Institute Now a Member of the Prestigious Pacific Pediatric NeuroOncology Consortium PNOC

About HMH Maestro

  • Accessibility Statement
  • Careers

Information

  • Visitors/Guests
  • Patients

Privacy Policy|Terms & Conditions
© 2026
Hackensack Meridian Health, Inc.